The Phase-I Clinical Trial Protocol for the Pandemic Inactivated Influenza Vaccine
Phase of Trial: Phase I
Latest Information Update: 23 Apr 2013
At a glance
- Drugs Influenza A virus vaccine-H5N1 (Primary)
- Indications Influenza A virus H5N1 subtype; Influenza A virus infections; Influenza virus infections
- Focus Adverse reactions; Pharmacodynamics
- Acronyms RDPCTPIIVHS
- Sponsors Sinovac Biotech
- 16 May 2008 Production license from the China State Food and Drug Administration (SFDA) for exclusive supply of Panflu to the national stockpiling program.
- 19 Apr 2006 New trial record.